QVA@ significantly reduced the rate of moderate to severe exacerbations versus glycopyrronium by @ % ( annualised rate of exacerbations @ -LSB- @ % CI @-@ -RSB- vs @ -LSB- @-@ -RSB- ; rate ratio @ , @ % CI @-@ , p = @ ) .